NCT04963335

Brief Summary

This study examines the feasibility and preliminary effects of user-centered exergames (video game-based physical exercise) in persons with multiple sclerosis (PwMS). The user-centered exergames were developed within a interdisciplinary team to meet the requirements of the end-users. The individualized exergames were designed for the Dividat Senso, a pressure sensitive plate connected to a personal computer and a frontal screen. This concurrent motor-cognitive training aims to improve motor and cognitive functions in an ecological valid setting. The cognitive functions are triggered by specific stimuli in the game scenarios. The video games are controlled via specific (whole body) movements as steps, weight shifting, jumps, and arm movements. The training focus is mainly on balance and coordination as well as executive functions and attention. Furthermore, the meaningful games (colorful and appealing visuals) were designed to motivate the players to move. Participants are allocated to the either the intervention group or the control group (quasi-randomization). Participants in the intervention group perform 16 training session over a period of 4 to 8 weeks (depending on in- or out-patient). One training session lasts between 15-25 minutes. Since the difficulty of the games is adaptive to the ability level of each participant, they should neither be over- nor under-challenged. Participates in the control group continue their normal daily routine over 8 weeks. Measurements are performed before, in-between, and after the intervention period to assess feasibility parameters as well as motor and cognitive functions in all participants.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
30

participants targeted

Target at P25-P50 for not_applicable multiple-sclerosis

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable multiple-sclerosis

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 28, 2021

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

April 19, 2021

Completed
3 months until next milestone

First Posted

Study publicly available on registry

July 15, 2021

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 31, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2021

Completed
Last Updated

July 15, 2021

Status Verified

July 1, 2021

Enrollment Period

4 months

First QC Date

April 19, 2021

Last Update Submit

July 5, 2021

Conditions

Keywords

ExergameMultiple SclerosisFeasibilityMotor functionsCognitive functions

Outcome Measures

Primary Outcomes (6)

  • Feasibility assessed by recruitment rate

    Recruitment rate is the number of study participants compared to the number of initial planned participants

    Through recruitment completion, an average of 12 weeks

  • Feasibility assessed by adherence rate

    Adherence rate is the number of attended training sessions compared to the number of planned trainings

    Through intervention completion, 4 to 8 weeks (depending on in- and outpatient)

  • Feasibility assessed by attrition rate

    Attrition rate is the number of dropouts

    Through study completion, an average of 20 weeks

  • Feasibility assessed by a safety protocol

    Safety protocol includes number of adverse events (including serious adverse events) and specific questions about safety issues

    Through study completion, an average of 20 weeks

  • System Usability

    The System Usability Scale interprets the system usability from 1 to 100, similar to a percentage score. A SUS score of at least 70 has to be reached to have an "acceptable" solution (52 = ok, 73 = good, 85 = excellent, 100 = best imaginable). The SUS consists of 10 items on a 5-point Likert scale and lasts about 3 minutes. The SUS is assessed at post-measurement.

    Through study completion, an average of 20 weeks

  • Feasibility, usability and training experience - Semi-structured interview

    The semi-structured interview contains pre-defined questions about user's gameplay experiences related to their body, controller, experience, virtual game scenario and safety. The interview lasts about 20 minutes and is assessed at post-measurement.

    Through study completion, an average of 20 weeks

Secondary Outcomes (7)

  • Changes in balance and mobility

    Through study completion, an average of 20 weeks

  • Changes in spatio-temporal gait parameters

    Through study completion, an average of 20 weeks

  • Changes in information processing speed

    Through study completion, an average of 20 weeks

  • Changes in executive functions - inhibition

    Through study completion, an average of 20 weeks

  • Changes in executive functions - flexibility

    Through study completion, an average of 20 weeks

  • +2 more secondary outcomes

Other Outcomes (7)

  • Training parameters

    Through intervention completion, 4 to 8 weeks (depending on in- and outpatient)

  • Training intensity

    Through intervention completion, 4 to 8 weeks (depending on in- and outpatient)

  • Training progress

    Through intervention completion, 4 to 8 weeks (depending on in- and outpatient)

  • +4 more other outcomes

Study Arms (2)

Intervention

EXPERIMENTAL

Participants perform 16 exergame training (video game-based physical exercise) sessions over a period of 4 to 8 weeks (depending on in-patient or out-patient). Each training lasts between 15 to 25 minutes. Exergames automatically adjust the game difficulty to the abilities of the respective participant.

Behavioral: Exergame Training

Control

NO INTERVENTION

Participants of the control group are instructed to continue their normal daily routine for eight weeks and to record their physical activities.

Interventions

The individualized exergames were designed for a pressure sensitive plate connected to a personal computer and a frontal screen. The pressure-sensitive plate allows a precise analysis of the user's movements. This concurrent motor-cognitive training aims to improve motor and cognitive functions in an ecological valid setting. The cognitive functions are triggered by specific stimuli in the game scenarios. The video games are controlled via specific (whole body) movements as steps, weight shifting, jumps, and arm movements. The training focus is mainly on multi-tasking, balance and coordination as well as executive functions and attention. Furthermore, the meaningful games (colorful and appealing visuals) were designed to motivate the players to move. As the exergame will automatically adapt (individual progression) during play time, participants are challenged at their individual motor and cognitive level.

Intervention

Eligibility Criteria

Age30 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Clinical diagnosis of MS
  • Able to provide written informed consent and understand instructions
  • Able to play the exergames by stepping and weight shifting
  • Able to walk at least 12m with or without walking aid
  • Visual acuity with correction sufficient to work on a TV screen

You may not qualify if:

  • Presence of musculoskeletal conditions that affect training performance
  • Excessive fatigue that impairs training participation
  • Exercise intolerance that prevents training participation
  • Rapidly progressive or terminal illness
  • Acute or unstable chronic illness

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ETH Zürich

Zurich, 8093, Switzerland

RECRUITING

MeSH Terms

Conditions

Multiple Sclerosis

Condition Hierarchy (Ancestors)

Demyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System Diseases

Central Study Contacts

Alexandra Schättin, Dr

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

April 19, 2021

First Posted

July 15, 2021

Study Start

March 28, 2021

Primary Completion

July 31, 2021

Study Completion

July 31, 2021

Last Updated

July 15, 2021

Record last verified: 2021-07

Locations